🇺🇸 FDA

Company profile · Sponsor

MiNK

MiNK Therapeutics

INKT · NYSE biotech NEW YORK, NY, USA
Pipeline
3
Drugs
0
Patents
6

Quick answer

MiNK (INKT) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 6 patents to this profile..

Company facts

Ticker INKT
Exchange NYSE
Company type biotech
Headquarters NEW YORK, NY, USA
SEC CIK 0001840229

Pipeline (3)

Search pipeline →

  1. agenT-797

    MiNK

    Relapsed/Refractory Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  2. agenT-797

    MiNK

    Respiratory Distress Syndrome, Adult

    phase 1 small molecule completed

    1 trial

  3. agenT-797

    MiNK

    Tumor, Solid

    phase 1 small molecule completed

    1 trial

Patents (6)

Search patents →

  1. US 12419955

    Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12391741

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11898165

    Engineered host cells and methods of use thereof

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11718658

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11613764

    T cell receptors that bind to NY-ESO-1 and methods of use thereof

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9943496

    Dietary supplement based on ethyl ferulate

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is MiNK?

MiNK (INKT) is a biotech company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 6 patents to this profile..

What pipeline programs does MiNK sponsor?

We track 3 ClinicalTrials.gov-linked programs for MiNK, including agenT-797 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does MiNK company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.